Pharmacist-based telemedicine models have sparse and weak evidence for chronic disease management, with only two adequately powered randomized trials showing positive impact in hypertension.
Does pharmacist-led telemedicine improve chronic disease management in the outpatient setting?
Current evidence for pharmacist-led telemedicine in chronic disease management is sparse and weak, precluding definitive conclusions despite potential opportunities to address primary care shortages.
Telemedicine refers to the delivery of clinical services using technology that allows two-way, real time, interactive communication between the patient and the clinician at a distant site. Commonly, telemedicine is used to improve access to general and specialty care for patients in rural areas. This review aims to provide an overview of existing telemedicine models involving the delivery of care by pharmacists via telemedicine (including telemonitoring and video, but excluding follow-up telephone calls) and to highlight the main areas of chronic-disease management where these models have been applied. Studies within the areas of hypertension, diabetes, asthma, anticoagulation and depression were identified, but only two randomized controlled trials with adequate sample size demonstrating the positive impact of telemonitoring combined with pharmacist care in hypertension were identified. The evidence for the impact of pharmacist-based telemedicine models is sparse and weak, with the studies conducted presenting serious threats to internal and external validity. Therefore, no definitive conclusions about the impact of pharmacist-led telemedicine models can be made at this time. In the Unites States, the increasing shortage of primary care providers and specialists represents an opportunity for pharmacists to assume a more prominent role managing patients with chronic disease in the ambulatory care setting. However, lack of reimbursement may pose a barrier to the provision of care by pharmacists using telemedicine.
Littauer et al. (Tue,) conducted a review in Chronic diseases (hypertension, diabetes, asthma, anticoagulation, depression). Pharmacist-led telemedicine models was evaluated. Pharmacist-based telemedicine models have sparse and weak evidence for chronic disease management, with only two adequately powered randomized trials showing positive impact in hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: